901
|
Speckman RA, Garg A, Du F, Bennett L, Veile R, Arioglu E, Taylor SI, Lovett M, Bowcock AM. Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C. Am J Hum Genet 2000; 66:1192-8. [PMID: 10739751 PMCID: PMC1288186 DOI: 10.1086/302836] [Citation(s) in RCA: 197] [Impact Index Per Article: 8.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2000] [Accepted: 02/14/2000] [Indexed: 11/03/2022] Open
Abstract
Familial partial lipodystrophy (FPLD), Dunnigan variety, is an autosomal dominant disorder characterized by marked loss of subcutaneous adipose tissue from the extremities and trunk but by excess fat deposition in the head and neck. The disease is frequently associated with profound insulin resistance, dyslipidemia, and diabetes. We have localized a gene for FPLD to chromosome 1q21-q23, and it has recently been proposed that nuclear lamin A/C is altered in FPLD, on the basis of a novel missense mutation (R482Q) in five Canadian probands. This gene had previously been shown to be altered in autosomal dominant Emery-Dreifuss muscular dystrophy (EDMD-AD) and in dilated cardiomyopathy and conduction-system disease. We examined 15 families with FPLD for mutations in lamin A/C. Five families harbored the R482Q alteration that segregated with the disease phenotype. Seven families harbored an R482W alteration, and one family harbored a G465D alteration. All these mutations lie within exon 8 of the lamin A/C gene-an exon that has also been shown to harbor different missense mutations that are responsible for EDMD-AD. Mutations could not be detected in lamin A/C in one FPLD family in which there was linkage to chromosome 1q21-q23. One family with atypical FPLD harbored an R582H alteration in exon 11 of lamin A. This exon does not comprise part of the lamin C coding region. All mutations in FPLD affect the globular C-terminal domain of the lamin A/C protein. In contrast, mutations responsible for dilated cardiomyopathy and conduction-system disease are observed in the rod domain of the protein. The FPLD mutations R482Q and R482W occurred on different haplotypes, indicating that they are likely to have arisen more than once.
Collapse
Affiliation(s)
- Rebecca A. Speckman
- Division of Human Genetics, Departments of Genetics and Pediatrics, Washington University School of Medicine, St. Louis; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas; and Diabetes Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda
| | - Abhimanyu Garg
- Division of Human Genetics, Departments of Genetics and Pediatrics, Washington University School of Medicine, St. Louis; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas; and Diabetes Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda
| | - Fenghe Du
- Division of Human Genetics, Departments of Genetics and Pediatrics, Washington University School of Medicine, St. Louis; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas; and Diabetes Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda
| | - Lynda Bennett
- Division of Human Genetics, Departments of Genetics and Pediatrics, Washington University School of Medicine, St. Louis; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas; and Diabetes Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda
| | - Rose Veile
- Division of Human Genetics, Departments of Genetics and Pediatrics, Washington University School of Medicine, St. Louis; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas; and Diabetes Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda
| | - Elif Arioglu
- Division of Human Genetics, Departments of Genetics and Pediatrics, Washington University School of Medicine, St. Louis; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas; and Diabetes Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda
| | - Simeon I. Taylor
- Division of Human Genetics, Departments of Genetics and Pediatrics, Washington University School of Medicine, St. Louis; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas; and Diabetes Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda
| | - Michael Lovett
- Division of Human Genetics, Departments of Genetics and Pediatrics, Washington University School of Medicine, St. Louis; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas; and Diabetes Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda
| | - Anne M. Bowcock
- Division of Human Genetics, Departments of Genetics and Pediatrics, Washington University School of Medicine, St. Louis; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas; and Diabetes Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda
| |
Collapse
|
902
|
Dalakas MC, Park KY, Semino-Mora C, Lee HS, Sivakumar K, Goldfarb LG. Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene. N Engl J Med 2000; 342:770-80. [PMID: 10717012 DOI: 10.1056/nejm200003163421104] [Citation(s) in RCA: 278] [Impact Index Per Article: 11.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
BACKGROUND Myofibrillar myopathies, often referred to as desmin-related myopathies, are a heterogeneous group of inherited or sporadic distal-onset skeletal myopathies associated with cardiomyopathy. Among the myofibrillar proteins that characteristically accumulate within the muscle fibers of affected patients, the one found most consistently is desmin, a muscle-specific intermediate-filament protein responsible for the structural integrity of the myofibrils. Skeletal and cardiac myopathy develops in mice that lack desmin, suggesting that mutations in the desmin gene may be pathogenic. METHODS We examined 22 patients from 8 families with dominantly inherited myofibrillar or desmin-related myopathy and 2 patients with sporadic disease and analyzed the desmin gene for mutations, using complementary DNA (cDNA) amplified from muscle-biopsy specimens and genomic DNA extracted from blood lymphocytes. Restriction-enzyme analysis was used to confirm the mutations. Expression vectors containing normal or mutant desmin cDNA were introduced into cultured cells to determine whether the mutant desmin formed intermediate filaments. RESULTS Six missense mutations in the coding region of the desmin gene that cause the substitution of an amino acid were identified in 11 patients (10 members of 4 families and 1 patient with sporadic disease); a splicing defect that resulted in the deletion of exon 3 was identified in the other patient with sporadic disease. Mutations were clustered in the carboxy-terminal part of the rod domain, which is critical for filament assembly. In transfected cells, the mutant desmin was unable to form a filamentous network. Seven of the 12 patients with mutations in the desmin gene had cardiomyopathy. CONCLUSIONS Mutations in the desmin gene affecting intermediate filaments cause a distinct myopathy that is often associated with cardiomyopathy and is termed "desmin myopathy." The mutant desmin interferes with the normal assembly of intermediate filaments, resulting in fragility of the myofibrils and severe dysfunction of skeletal and cardiac muscles.
Collapse
Affiliation(s)
- M C Dalakas
- Neuromuscular Diseases Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892-1382, USA.
| | | | | | | | | | | |
Collapse
|
903
|
Abstract
Autosomal dominant partial lipodystrophy (PLD), in which regional adipose loss is coupled with insulin resistance, is strongly associated with missense mutations in LMNA, encoding lamin A/C-a component of the nuclear envelope. This finding indicates that other proteins and functions of the nuclear envelope may have bearing on disorders of adipose tissue and insulin action.
Collapse
|
905
|
Shackleton S, Lloyd DJ, Jackson SN, Evans R, Niermeijer MF, Singh BM, Schmidt H, Brabant G, Kumar S, Durrington PN, Gregory S, O'Rahilly S, Trembath RC. LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nat Genet 2000; 24:153-6. [PMID: 10655060 DOI: 10.1038/72807] [Citation(s) in RCA: 478] [Impact Index Per Article: 19.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
Abstract
The lipodystrophies are a group of disorders characterized by the absence or reduction of subcutaneous adipose tissue. Partial lipodystrophy (PLD; MIM 151660) is an inherited condition in which a regional (trunk and limbs) loss of fat occurs during the peri-pubertal phase. Additionally, variable degrees of resistance to insulin action, together with a hyperlipidaemic state, may occur and simulate the metabolic features commonly associated with predisposition to atherosclerotic disease. The PLD locus has been mapped to chromosome 1q with no evidence of genetic heterogeneity. We, and others, have refined the location to a 5.3-cM interval between markers D1S305 and D1S1600 (refs 5, 6). Through a positional cloning approach we have identified five different missense mutations in LMNA among ten kindreds and three individuals with PLD. The protein product of LMNA is lamin A/C, which is a component of the nuclear envelope. Heterozygous mutations in LMNA have recently been identified in kindreds with the variant form of muscular dystrophy (MD) known as autosomal dominant Emery-Dreifuss MD (EDMD-AD; ref. 7) and dilated cardiomyopathy and conduction-system disease (CMD1A). As LMNA is ubiquitously expressed, the finding of site-specific amino acid substitutions in PLD, EDMD-AD and CMD1A reveals distinct functional domains of the lamin A/C protein required for the maintenance and integrity of different cell types.
Collapse
Affiliation(s)
- S Shackleton
- Division of Medical Genetics, Departments of Medicine and Genetics, University of Leicester, Leicester, UK
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|